SCHEMBL3932271

SCHEMBL3932271

O=C(O)N[C@H]1CN(Cc2ccccc2)C[C@H]1N1CCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ S1PR1 P21453 1/20 0.40
▸ S1PR5 Q9H228 1/20 0.40
▸ DPP7 Q9UHL4 1/20 0.40
▸ SCN4A P35499 2/20 0.40
▸ BCHE P06276 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ FUCA1 P04066 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3932267 1.00 L3MBTL1 (0.41) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL3922813 0.97 L3MBTL1 (0.44) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL3922808 0.97 L3MBTL1 (0.44) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL149953 0.85 KMT2A (0.48) L3MBTL1DRD2KMT2ABCHEMAOB
SCHEMBL146760 0.82 KMT2A (0.47) L3MBTL1KMT2ABCHEMAOBACHE
SCHEMBL459673 0.82 KMT2A (0.47) L3MBTL1KMT2ABCHEMAOBACHE
SCHEMBL146759 0.82 KMT2A (0.47) L3MBTL1KMT2ABCHEMAOBACHE
SCHEMBL1721376 0.81 S1PR1 (0.37) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL3926744 0.81 S1PR1 (0.37) L3MBTL1POLBDRD2DRD4DRD3
SCHEMBL3926747 0.81 S1PR1 (0.37) L3MBTL1POLBDRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7485641-B2 Substituted 3-amino-pyrrolidino-4-lactams PFIZER, INC. (US) 2009-02-03 — — US disclosed
US-20070299076-A1 Substituted 3-Amino-Pyrrolidino-4-Lactams PFIZER INC 2007-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299076-A1 Substituted 3-Amino-Pyrrolidino-4-Lactams PRMT1, PRMT7, PRMT3 L3MBTL1 4488/4885POLB 2789/4885DRD2 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback